Urinary Collection Devices for Bedwetting
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two devices designed to help women manage bedwetting due to urinary incontinence. Researchers aim to determine which device is safer for the skin and more effective at collecting urine overnight. Women who regularly use diapers at night for urinary incontinence may be suitable for this study. Participants will use each device for four weeks to help identify which one performs best. As an unphased trial, this study allows participants to contribute to research that could enhance the quality of life for women facing similar challenges.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that these urinary collection devices are safe for women with urinary incontinence?
Research shows that the Hollister® Female Urinary Pouch is designed for women with limited mobility who need assistance managing urine flow. It features a SoftFlex™ skin barrier that can be trimmed for a comfortable and personalized fit, likely enhancing user comfort.
For the PureWick™ System, although detailed safety information is limited, it is generally considered safer than traditional catheters, which often carry a higher risk of infections. It is important to avoid using the PureWick™ with materials that block airflow, as this could cause discomfort.
Both devices have been used outside of clinical trials, suggesting they are safe for public use. However, those considering joining a trial should discuss any potential risks with their healthcare provider.12345Why are researchers excited about this trial?
Researchers are excited about these urinary collection devices for bedwetting because they offer non-invasive, external solutions compared to traditional options like absorbent pads or medication. The PureWick™ System uses a gentle suction technique to wick urine away from the body, which can significantly reduce skin irritation and improve comfort. The Hollister® Female Urinary Pouch offers a discreet and secure way to collect urine externally, potentially enhancing convenience and dignity for users. These innovative methods provide promising alternatives that could improve quality of life for those experiencing bedwetting.
What evidence suggests that these urinary collection devices are effective for bedwetting?
This trial will compare the effectiveness of two urinary collection devices for managing bedwetting. Research has shown that the PureWick™ System, which participants in this trial may use, effectively manages urinary incontinence in women. In one study, 64% of users in care settings preferred it over traditional pads, finding it more satisfying and convenient, suggesting it manages urine better.
The Hollister® Female Urinary Pouch, another device tested in this trial, is designed to collect urine for those with incontinence. Its custom-fit feature aims to improve comfort and effectiveness in managing urine. Both devices offer non-invasive ways to handle nighttime bedwetting, focusing on capturing urine efficiently and safely.13678Are You a Good Fit for This Trial?
This trial is for adult women over 18 with urinary incontinence who use diapers at night. Participants must be willing to follow the study procedures and provide consent. It's not suitable for those with frequent bowel incontinence without management, heavy menstruation unable to use tampons or cups, active infections, urinary retention, combative behavior, genital wounds or irritations, certain neurological conditions, pregnancy or any condition that may affect self-reporting.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase 1
Participants use the first assigned device (either PureWick™ System or Hollister Female Urinary Pouch) overnight for 4 weeks
Washout
A washout period between treatment phases to ensure no carryover effects
Treatment Phase 2
Participants switch to the second assigned device and use it overnight for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hollister® Female Urinary Pouch External Collection Device
- PureWick™ System
Find a Clinic Near You
Who Is Running the Clinical Trial?
C. R. Bard
Lead Sponsor
Timothy M. Ring
C. R. Bard
Chief Executive Officer since 2003
Bachelor of Science in Industrial and Labor Relations from Cornell University
Dr. Cimler
C. R. Bard
Chief Medical Officer since 2017
Ph.D. in Pharmacology
Becton, Dickinson and Company
Industry Sponsor
Tom Polen
Becton, Dickinson and Company
Chief Executive Officer since 2020
Bachelor’s degree from Salisbury University, MBA from Johns Hopkins University
Meera Gopalakrishnan
Becton, Dickinson and Company
Chief Medical Officer
Ph.D. in Biomedical Engineering from the University of Memphis